ALTER-PA001: A multicenter, randomized study of anlotinib and benmelstobart in combination with AG chemotherapy vs. AG as first-line treatment for metastatic pancreatic cancer.
Authors: Jiujie Cui, Wei Li, Jingyu Cao, Yingzhi Lu, Ming Quan, Jun Wu, Mei Zhang, Da Li, Xiujuan Qu, Zhiwei Li, Liwei Wang